Rockefeller generic bill
Executive Summary
Sen. Jay Rockefeller (D-W.Va.) is expected to introduce legislation addressing use of generic drugs and biologics during the week of June 17 (1"The Pink Sheet" May 6, p. 9)...
You may also be interested in...
Generic Biologics Commission Urged; McCain Abjures Bioterrorism Add-On
Sen. Jay Rockefeller (D-W.Va.) is expected to introduce legislation that would create a commission to examine the possibility of generic biologics
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.